Objectives-Sphingosine 1-phosphate (S1P) is a bioactive phospholipid acting both as a ligand for the G protein-coupled receptors S1P 1-5 and as a second messenger. Because S1P 1 knockout is lethal in the transgenic mouse, an alternative approach to study the function of S1P 1 in endothelial cells is needed. Methods and Results-All human endothelial cells analyzed expressed abundant S1P 1 transcripts. We permanently silenced (by RNA interference) the expression of S1P 1 in the human endothelial cell lines AS-M.5 and ISO-HAS.1. The S1P 1 knock-down cells manifested a distinct morphology and showed neither actin ruffles in response to S1P nor an angiogenic reaction. In addition, these cells were more sensitive to oxidant stress-mediated injury. New S1P 1 -dependent gene targets were identified in human endothelial cells. S1P 1 silencing decreased the expression of platelet-endothelial cell adhesion molecule-1 and VE-cadherin and abolished the induction of E-selectin after cell stimulation with lipopolysaccharide or tumor necrosis factor-␣. Microarray analysis revealed downregulation of further endothelial specific transcripts after S1P 1 silencing. Conclusions-Long-term silencing of S1P 1 enabled us for the first time to demonstrate the involvement of S1P 1 in key functions of endothelial cells and to identify new S1P 1 -dependent gene targets. (Arterioscler Thromb Vasc Biol. 2005; 25:546-552.)
T he bioactive sphingolipid metabolite, sphingosine 1-phosphate (S1P), is an important component of serum that is released primarily from activated platelets. S1P is a multifunctional physiologic mediator implicated in the regulation of a broad spectrum of biologic processes, including proliferation, survival, regulation of cytoskeletal reorganization, motility, and differentiation in many cell types. [1] [2] [3] [4] [5] The response of cells to S1P has been shown to be mediated predominantly by G protein-coupled receptors. Five receptors encoded by the endothelial differentiation gene family that bind S1P with high affinity have been described. 6 -10 The receptors couple to multiple G proteins that activate different intracellular signaling pathways. Several of these receptors are simultaneously coexpressed on the same cell.
In addition to acting as a ligand of cell surface receptors, S1P can function as a second messenger. 3, 4, 11 A variety of external stimuli, particularly growth factors and chemoattrac-tants, as well as lysophosphatidic acid and S1P, have been reported to strongly stimulate S1P kinase (SphK) to generate intracellular S1P, which can mobilize calcium from internal stores, 12 regulate cell survival by activating the transcription factor nuclear factor-B, 13 and control cell proliferation by mediating Ras and extracellular signal-regulated kinase 1/2 activation in cells stimulated with vascular endothelial growth factor (VEGF). 14 Stimulation of the S1P 1 receptor (previously known as endothelial differentiation gene-1, edg-1) activates a G ilinked pathway leading to cell growth, survival, and migration. 15, 16 The signaling pathways mediating these responses include activation of the Ras and Rho GTPases, which direct mitogenesis and cytoskeletal remodeling, respectively. S1P 1 receptor-knockout mice are not viable and die in utero because of defects in vascular maturation. 17 Coordinate endothelial expression of S1P 1 , S1P 2 , and S1P 3 is essential for embryonic development. 18, 19 The cytoskeletal and morphogenic response of human umbilical vein endothelial cells (HUVECs) to S1P has been evaluated with the use of antisense oligonucleotides directed against S1P 1 and S1P 3 . 20 -22 Receptor expression inhibition studies indicated that S1P 1 couples to Rac, regulating cortical actin assembly, whereas S1P 3 couples to Rho, involved in stress fiber formation. 20 However, measurements of Rac and Rho activity by biochemical assays indicated that both receptors are capable of activating both Rac and Rho pathways involved in migration and morphogenic differentiation of endothelial cells into capillary-like structures. 21 Both receptors mediate the activation of membrane type 1-matrix metalloproteinase by S1P. 22 To analyze the function of S1P 1 in human endothelial cells, we generated human endothelial cell lines with a permanently reduced expression of S1P 1 by introducing plasmids encoding small interfering RNA (siRNA) targeted to S1P 1 into the cell lines AS-M.5 23 and ISO-HAS.1. 24, 25 The use of established human endothelial cell lines enabled us to study the long-term functional consequences of S1P 1 silencing.
Methods
Please see the expanded online Methods section at http://atvb. ahajournals.org.
Cell Culture
HUVECs were isolated as described 26 and propagated in ECG medium (PromoCell). The human cell lines derived from human pulmonary microvascular endothelial cells (HPMEC-ST1.6R) 27 and from patients with angiosarcoma (AS-M.5 23 and ISO-HAS.1 24, 25 ) were cultured in ECG medium-MV (PromoCell).
Cloning of siS1P 1 Sequences
The S1P 1 -specific siRNA expression vectors were generated by cloning the sequences encoding the hairpin siRNA targeted to S1P 1 into the siRNA expression vector pSilencer 1.0-U6 (Ambion, Austin, Tex). The targeted sequences were as follows: #1, 5Ј-GGAGATGCGTCGGGCCTTC-3Ј; #2, 5Ј-CTGCATCAGTG-CGCTGTCC-3Ј; and #3, TGATCGATCATCTATAGCA-3Ј, located at bp 1196 to 1214, 797 to 816, and 1940 to 1958, respectively (NCBI accession number BC018650). The control plasmid was pSilencer negative control (Silco) that encodes siRNA having no significant sequence similarity to human gene sequences (Ambion). The secondary structure was determined by using the Vienna RNA secondary structure prediction program. 28
Generation of S1P 1 -Knock-Down Endothelial Cell Lines
Plasmids encoding siRNA targeted to the S1P 1 transcript were introduced into endothelial cells, and stably transfected cells were selected as described at www.ahajournals.org.
Results

Expression Profile of S1P Receptors in Cultured HUVECs
Transcripts encoding S1P 1 were abundant in all cultures of endothelial cells tested. Transcripts encoding S1P 3 were detected by reverse transcription-polymerase chain reaction (RT-PCR) in all but ISO-HAS.1 cells ( Figure 1 ). By quantitative RT-PCR, the S1P 3 transcripts were less abundant than S1P 1 transcripts, representing 4.3%, 3.5%, and 0.75% of S1P1 expression levels in HUVEC, AS-M.5, and ISO-HAS.1, respectively. A very weak expression of S1P 4 was observed in HUVECs, ISO-HAS, and a subclone of HPMEC-ST1.6R, designated HPMEC-ST1.6R.D. Transcripts encoding either S1P 2 or S1P 5 were not detected ( Figure 1 ).
siRNA Efficiently Reduces the Concentration of S1P 1 Transcripts
To gain insight into the biologic function of S1P 1 in human endothelial cells, we introduced into the cell lines AS-M.5 and ISO-HAS.1 plasmids encoding siRNA targeted to 3 different sequences in the S1P 1 transcript (Sil#1, Sil#2, Sil#3) and isolated stably transfected cells. We measured by quantitative RT-PCR the levels of S1P 1 transcripts in the transfected cells and compared these with unmanipulated cells and with cells stably transfected with a control plasmid (Silco; Figure 2 ). The levels of S1P 1 transcripts differed substantially between the different cells. In the AS-M.5 cells transfected with Sil#1 (AS-M.5-Sil#1), S1P 1 transcripts were repeatedly reduced to Ϸ20% of levels detected in either AS-M.5 or AS-M.5-Silco cells ( Figure  2 ). We isolated single cell-derived clones of AS-M.5-Sil#1 and analyzed them for expression of S1P 1 . Individual clones (cl.) differed in the levels of S1P 1 expression, reaching average values of 15% to 70% of S1P 1 levels detected in the control pool of cells ( Figure 2) . The low S1P 1 expression level remained stable for at least 6 months in a selected clone, AS-M.5-Sil#1, T2, cl.3. In contrast, expression of S1P 1 in the cells containing the construct Sil#2 and Sil#3 was reduced to only 60% of control or not affected, respectively ( Figure 2 ). The 3 pSil-derived plasmids encoding siRNA sequences targeted to S1P 1 transcript also were stably introduced into HPMEC.ST1.6R, 27 subclones D and S, AS-M.5, 23 and HUVECs was analyzed for expression of S1P 1 , S1P 2 , S1P 3 , S1P 4 , S1P 5 , and ␤-actin. RT-PCR products were separated on agarose gel and stained with ethidium bromide. Abbreviations are as defined in text.
the ISO-HAS.1 cell line. In this cell line, only the pSil#1 construct was efficient in reducing the expression of S1P 1 (Figure 2 , dark gray bars). S1P 1 expression in single cell-derived clones of these cells was stably reduced by 50% to 80%.
The low expression of S1P 3 transcripts, as measured by quantitative RT-PCR, was unchanged in the clones of S1P 1knockdown AS-M.5 clones (T2, Sil#1, cl.2, 3, and 6) and also not affected by transfection of ISO-HAS.1 with Sil#1 plasmid (not shown), suggesting that S1P 1 downregulation had no effect on expression of S1P 3 .
Cells With Reduced S1P 1 Expression Display Altered Morphology and Have Altered Proliferation Characteristics
The S1P 1 -knockdown AS-M.5 cells exhibited a distinctive morphology ( Figure Ia . S1P 1 -knockdown cells contained vesicles on their surface, a feature that was more prominent in lowdensity cultures ( Figure Ia, B ). These profound changes in cellular morphology were observed in cultures of AS-M.5 cells transfected with the construct Sil#1 before the clonal selection in 2 independent experiments. After single-cell cloning, 3 single cell-derived clones with very low S1P 1 expression levels (T2, cl.2, 3, and 6) displayed this morphology, suggesting that this morphology may be correlated with the low expression of S1P 1 . In low-density cultures, AS-M.5-pSil#1 cells grew considerably slower than did the control AS-M.5 cells (not shown). However, no major differences in growth characteristics were observed in high-density cultures, suggesting that the AS-M-Sil#1 cells may depend on substances released by neighboring cells available in high-density cultures.
S1P 1 -Knockdown Cells Do Not Show S1P-Induced Reorganization of Actin
S1P-induced remodeling of the actin cytoskeleton is a characteristic response in many cell types. To verify the role of S1P 1 in this reaction, we evaluated cytoskeletal responses in serum-starved cells. Confluent monolayers of both AS-M.5 and AS-M.5-Silco cells showed F-actin fibers distributed throughout the cytoplasm ( Figure Ib , A and C). Treatment with S1P for 2 minutes caused spectacular reorganization of the actin cytoskeleton: fibers of F-actin were concentrated at cell-to-cell contacts in confluent cultures (Figure Ib, D and F) and into a subcortical network in subconfluent cultures (not shown). In contrast, neither actin fibers nor a response to S1P treatment was observed in AS-M.5-Sil#1 cells ( Figure Ib, B and E). These observations demonstrate that the S1P 1 receptor is essential for the reorganization of the actin cytoskeleton induced by S1P in human endothelial cells.
S1P 1 Is Indispensable for the Angiogenic Response of Endothelial Cells
To evaluate the effect of reduced expression of S1P 1 on the angiogenic reaction, we examined endothelial morphogenesis into capillary-like networks. Capillary formation was evaluated after 6 ( Figure 3A Figure 3B and 3E) . Therefore, S1P 1 is required for the angiogenic reaction of endothelial cells. A similar angiogenic reaction was observed in ISO-HAS.1 cells expressing S1P 1 but very little S1P 3 (not shown). 
Responses to Oxidative Stress in S1P 1 -Knockdown Cells
The response to oxidative stress induced by 4-hydroxynonenal (4-HNE; 10 to 20 mol/L, 6 hours, 37°C) was evaluated by quantifying the ratio of necrotic to apoptotic cells. The percentage of both apoptotic and necrotic cells increased dependent on the concentration of 4-HNE and reached Ϸ10% in ISO-HAS.1 (not shown) and AS-M.5 cells. Whereas apoptosis was the same in control and AS-M.5-sil#1 cells, the proportion of necrotic cells in AS-M.5-Sil#1 cultures increased dramatically after 4-HNE treatment, attaining 30% ( Figure II , available online at http://atvb.ahajournals.org). (Figure 4b, B and E). Gene expression analyses by microarrays showed downregulation of transcripts encoding PECAM-1 and VE-cadherin in 2 different clones of S1P 1 -silenced AS-M.5 cells (Table I , available online at http://atvb.ahajournals.org). These observations indicate that S1P 1 is required for gene transcription and expression of VE-cadherin and PECAM-1 in human endothelial cells.
Reduced S1P 1 Expression Abolishes the Expression of Cell Adhesion Molecules
S1P 1 Modulates the Endothelial Cell Response to Proinflammatory Stimuli
Similar to freshly isolated HUVECs that respond to proinflammatory stimuli by the transcriptional upregulation of cell adhesion molecules, both AS-M.5 (not shown) and AS-M.5-Silco cells responded to stimulation by tumor necrosis factor-␣ (TNF-␣) (100 ng/mL, 6 hours) and lipopolysaccharide (LPS; 1 g/mL, 6 hours) by a transient induction of transcription of E-selectin and intercellular adhesion molecule-1 (ICAM-1) on the cell surface ( Figure  4c ). Albeit diminished in comparison with the control cells, induction of ICAM-1 expression in response to TNF-␣ and LPS was clearly detectable in the knockdown AS-M.5 cells. However, in contrast to either the AS-M.5 or AS-M.5-Silco cells, no induction of E-selectin production was observed in AS-M.5-Sil#1 (Figure 4c ). Analysis of E-selectin transcripts by real-time RT-PCR showed that E-selectin transcripts were highly reduced in the LPSstimulated, S1P 1 -knockdown cells compared with the control cells, suggesting that E-selectin expression was regulated at the transcriptional level (not shown). Thus, we conclude that S1P 1 is involved in the regulation of the inflammatory response of endothelial cells.
Microarray Analysis of Genes Expressed in S1P 1 -Silenced Endothelial Cells
Searching for gene targets that are dependent on S1P 1 expression, we compared gene expression patterns of 2 clones of S1P 1 -knockdown AS-M.5 cells (T2, cl.2 and cl.3) with those of AS-M.5-Silco and AS-M.5. Among the 22 238 gene probes that the microarrays contained, we identified 82 genes with increased expression and 220 downregulated transcripts in the S1P 1 -knockdown cells (2-fold decrease and increase; error probability Ͻ5%). Many endothelial specific transcripts were downregulated (Table II , available online at http:// atvb.ahajournals.org), but the expression of other genes was not affected in the S1P 1 -knockdown AS-M.5 cells. The latter genes include angiotensin II receptor (Hs.405348), endothe- lial lipase (Hs.65370), endothelin-2 (Hs.1407), nitric oxide synthetase-3 (NOS3, Hs.446303), P-selectin (Hs, 73800), the VEGF receptor FLT1 (Hs.347713), and fms-related tyrosine kinase FLT3 (Hs.385), vimentin (Hs.43800), and vitronectin (Hs.2257; not shown).
Discussion
The analysis of expression profiles of S1P receptors showed that all human endothelial cells tested (AS-M.5, 23 ISO-HAS.1, 24,25 HPMEC-ST1, 27 and HUVECs) expressed transcripts encoding S1P 1 , suggesting that the S1P 1 receptor may have a ubiquitous function in endothelial cells. All human endothelial cells tested also contained transcripts encoding S1P 3 , at a much lower level, however, as measured by quantitative RT-PCR. Expression of both S1P 1 and S1P 3 characterizes the typical expression pattern of S1P receptors in cultured human endothelial cells. 20 To examine the function of S1P 1 in human endothelial cells, we permanently silenced by RNA interference the expression of S1P 1 in the established endothelial cell lines AS-M.5 and ISO-HAS.1, previously shown to possess many characteristics of freshly isolated endothelial cells. [23] [24] [25] The siRNA targeted to a large loop in the secondary structure of the S1P 1 transcript (Sil#1) was more efficient in silencing than were the less exposed sequences (Sil#2, Sil#3) in the S1P 1 transcripts. A similar observation was reported for silencing of the insulin-like growth factor receptor, 29 suggesting that the secondary structure of the targeted transcripts may be important for efficient silencing by siRNA. The reduction of S1P 1 expression in the cells transfected with plasmids Sil#1 did not affect the already very low level of S1P3 expression and was stable for at least 6 months of continuous culturing.
Silencing of S1P 1 transcripts to Ͻ20% of control profoundly altered the phenotype of endothelial cells. The S1P 1 -knockdown endothelial cells (AS-M.5-Sil#1) manifested an altered morphology and proliferated slowly in low-density cultures. In contrast to the control cells showing spectacular reorganization of the actin cytoskeleton in response to S1P, the S1P 1 -knockdown AS-M.5 cells showed no reorganization of actin after S1P treatment. Actin reorganization is an immediate response triggered by S1P. 20, 30 It has been reported to be regulated through balance between Rho and Rac activity in HUVECs 21, 31 and to be correlated with an enhancement of endothelial cell barrier function. 32 Our results demonstrate that the S1P 1 receptor is required for S1P-induced actin reorganization in human endothelial cells.
The S1P 1 -knockdown cells exhibited altered angiogenic properties. No formation of typical capillary-like networks of differentiated endothelial cells on Matrigel could be observed with AS-M.5-Sil#1, consistent with the reports on the involvement of S1P 1 in angiogenesis. 33 Both the lack of angiogenic response of AS-M.5-Sil#1 and the capacity to form capillary-like structures 34 of ISO-HAS.1 expressing S1P 1 but almost no S1P 3 suggest that S1P 1 but not S1P 3 is essential for endothelial cell morphogenesis. However, we cannot exclude a cooperative effect of S1P 1 and S1P 3 previously observed in short-term inhibition studies with antisense oligonucleotides. 20 In a recent study, downregulation of S1P 1 expression effectively suppressed tumor angiogenesis in a murine model in vivo. 35 We observed an increased proportion of both apoptotic and necrotic cells in both control and AS-M.5-Sil#1 cells after treatment with 4-HNE, a mediator of oxidative stress 36 shown to induce apoptotic death in HUVECs. 37 Whereas no major difference between control and AS-M.5-Sil#1 cells was observed in the proportion of apoptotic cells, the proportion of necrotic cells in AS-M.5-Sil#1 increased significantly. S1P has been previously reported to activate SphK, which results in the intracellular production of S1P and has an antiapoptotic effect in endothelial cells. 38, 39 However, our observations indicate that S1P 1 is not involved in the antiapoptotic activity of S1P but may rather protect endothelial cells from necrosis.
Long-term silencing of S1P 1 enabled us to identify new S1P 1 -dependent gene targets in endothelial cells. Downregulation of S1P 1 led to a reduced expression of the adhesion molecules PECAM-1, expressed predominantly at the endothelial cell contacts, 40 and VE-cadherin, usually expressed at intercellular junctions. 41 The degree of S1P 1 knockdown was correlated with the extent of suppression of PECAM-1 and VE-cadherin. This suggests that the expression of these surface molecules is controlled by S1P 1 . VE-cadherin expression was previously reported to be reduced after injection of antisense oligonucleotides directed against S1P 1 into HUVECs. 20 Because functional VE-cadherin was demonstrated to be required for endothelial cell morphogenesis 42 and PECAM-1-null endothelial cells failed to migrate in response to S1P, 43 the lack of expression of both VE-cadherin and PECAM-1 in S1P 1 knockdown endothelial cells may impede their morphogenetic reaction on Matrigel.
The S1P 1 -knockdown endothelial cells differed from the control cells also in their response to proinflammatory stimuli. Silencing of S1P 1 had no major effect on LPSinduced expression of ICAM-1 but reduced the TNF-␣stimulated expression of ICAM-1 by 60%. No expression of E-selectin in response to stimulation with either LPS or TNF-␣ was observed in the S1P 1 -knockdown endothelial cells, implicating involvement of S1P 1 in the regulation of E-selectin expression. Several lines of evidence suggest a possible participation of S1P in the inflammatory reaction of endothelial cells. TNF-␣ was found to induce rapid activation of SphK and subsequent generation of intracellular S1P that resulted in strong stimulation of E-selectin expression in HUVECs. 44 The defective control of E-selectin expression in the S1P 1 knockdown cells suggests that a functional S1P 1 receptor is required to mediate expression of E-selectin in stimulated endothelial cells and implies that the intracellularly produced S1P does not function as a second messenger but rather is released from the cells and then activates S1P 1 . S1P treatment of confluent HUVEC cultures was reported to induce the expression of E-selectin to levels comparable to those induced with TNF-␣ in 1 44 but not in another 45 study, Also, we found only negligible induction of E-selectin expression after S1P treatment of both HUVEC and AS-M.5 cultures (not shown). The latter observations suggest that a synergistic interaction of the signal transduction pathways induced by TNF-␣ and S1P 1 receptor activation is required for robust E-selectin expression observed after treatment of endothelial cells with TNF-␣.
Further S1P 1 -dependent gene targets were identified by microarray analysis of gene expression. Many endothelial specific transcripts, such as the VEGF-receptor KDR, were downregulated in S1P 1 -silenced endothelial cells, but other endothelial specific genes, such as the VEGF-receptor Flt-1 and the fms-related kinase Flt-3, were not affected.
In conclusion, our results demonstrate that long-term silencing of S1P 1 profoundly alters gene expression and key functions of cultured human endothelial cells. This observation, if confirmed in vivo, could have important therapeutic consequences for chronic inhibition of the S1P 1 receptor with receptor antagonists or low concentrations of agonists leading to S1P 1 downregulation. The immunosuppressive drug FTY720, an agonist of S1P-receptors currently used in clinical trials, at therapeutic concentrations has been recently reported to block S1P signaling through downregulation of S1P 1,2,5 . 46 Our results imply that FTY720 could be harmful if it induced downregulation of S1P 1 on vascular endothelium in vivo.
